Conditions considered together
- Metabolic fatty liver and abnormal liver enzymes
- High cholesterol or triglycerides
- Hypertension and cardiovascular risk
- Raised uric acid or gout risk
- Prediabetes, insulin resistance and metabolic syndrome
Fatty liver requires risk assessment—not a “detox”
The important questions are why fat has accumulated in the liver, whether there are signs of inflammation or fibrosis, and how diabetes, weight, lipids, alcohol, medicines and other causes contribute. Treatment focuses on evidence-based risk reduction. Advanced or uncertain liver disease may require gastroenterology or hepatology assessment.
Read the dedicated fatty-liver and MASLD care pathway →
High uric acid is not always treated the same way
A raised laboratory value alone is different from recurrent gout, kidney stones or other complications. Decisions depend on symptoms, level, kidney function, medicines and overall risk.
Read the high uric acid and gout-risk pathway →
Cholesterol treatment depends on total risk
LDL cholesterol, triglycerides and other lipid markers should be interpreted alongside age, diabetes, blood pressure, smoking, kidney health, fatty liver, family history and previous cardiovascular disease. A single laboratory flag is not the complete risk assessment.
Read the cholesterol and triglyceride care pathway →
Do not stop blood pressure, lipid or uric-acid medicine based on website information. Treatment decisions require an individual review.